The Challenge
A large Life Sciences organization had a long running Patient Solutions Program and wanted to implement structural changes as the product neared Loss of Exclusivity.
The organization was struggling to assess the impact of the changes and provide meaningful recommendations to drive value in a cost-constrained environment.
Our Solution
Propensity4 integrated available data across phone and digital engagement. We conducted an engagement analysis to understand:
- Demographics of the program vs. the patient population
How patients were engaging and disengaging
The impact on engagement as changes were implemented
Provided recommendations on how to make the program more efficient within new budget constraints.
The Results
Propensity4 was able to map the flow of the program versus its initial design. The client was able to clearly understand engagement changes versus baseline due to program changes.
Propensity4 was able to provide recommendations on modifications to the SMS program to increase digital and overall engagement. Client and Propensity4 were able to develop recommendations on future pilots to refine the program to match patient preferences and drive further savings.
|
64% |
64% |
| Engaged patients over the age of 50 |
Trained patients initially enrolled over the phone |
Learn more about our work.
Jump to a slide with the slide dots.
Welcome to the Team: Isabelle Amick, Senior Director of Data Science
We’re thrilled to announce that Isabelle Amick has joined Propensity4 as our new Senior Director of Data Science!
Read more
Powering a U.S. Launch: Building a Commercial Infrastructure from the Ground Up
End-to-end US launch support for EU client’s dry eye device—from KAM team and CRM setup to data analytics, targeting, and incentive strategy.
Read more
Chris Savage
Improve your forecast with “bottom-up” methodologies
This blog explores how “bottom-up” forecasting, particularly Most Probable Forecasting (MPF), enhances pharmaceutical brand planning.
Read more
Predictive Patient Engagement Program
Personalized patient engagement boosted therapy adherence with AI-driven insights, risk scoring, and tailored support recommendations.
Read more
Isabelle Amick
Rare-disease patient finding: Identifying the “right” patients at the “right” time.
Accelerating rare disease diagnosis through data-driven patient finding and predictive modeling to connect patients with the right HCPs faster.
Read more